Clinical Trials Browser

Phase 2 × Brain Neoplasms × brigatinib × Clear all

NCT04634110 2022-10-24

Brigatinib Before Brain Irradiation Trial (B3i Trial)

Phase 2 Terminated

1 enrolled 6 charts

Brain Neoplasms, Lung Neoplasms

NCT03868423 2022-02-18

Brigatinib in Treating Patients With ALK and ROS1 Gene Alterations and Locally Advanced or Metastatic Solid Cancers

Phase 2 Withdrawn

Brain Neoplasms, Neoplasm Metastasis